Holen Sie sich die Stockscreener-App
541.70
5.19%
-29.68
Handel nachbörslich:
541.70
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
United Therapeutics Corp Stock (UTHR) Moved Up by 7.26% on Oct 1: What Investors Need To Know - TradingKey
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback - Zacks Investment Research
This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - TradingView
Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet - FinancialContent
Here Are Thursday’s Top Wall Street Analyst Research Calls: BP, Dollar Tree, Exxon Mobil, Lennar, Occidental Petroleum, Rocket Lab, Teva Pharmaceuticals, United Therapeutics, and More - Yahoo Finance
United Therapeutics Stock Rises Following Federal Court Patent Victory Over Liquidia - Benzinga
Cantor Fitzgerald reiterates United Therapeutics stock rating after patent win - Investing.com
BTIG upgrades United Therapeutics stock rating on legal win - Investing.com
Why is United Therapeutics stock gaining today? - Investing.com
United Therapeutics Corporation wins Yutrepia PH‑ILD patent ruling - Mugglehead Investment Magazine
Liquidia Corp. Shares Edge Higher After HoursUnited Therapeutics (NASDAQ:UTHR), Liquidia (NASDAQ:LQDA) - Benzinga
Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today - Yahoo Finance
United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia - Yahoo Finance
United Therapeutics (UTHR) Shares Surge 13% After Favorable Pate - GuruFocus
Liquidia Loses Bid to Nix United Therapeutics Lung-Drug Patent - Bloomberg Law News
A Look at United Therapeutics Corp (UTHR) After 12.6% Gain -- GF Value $428.32 vs Price $541.89 - GuruFocus
A CEO’s trust exercises options and sells 9,500 United Therapeutics (UTHR) shares under a trading plan. - Stock Titan
United Therapeutics jumps 13% on court ruling (UTHR:NASDAQ) - Seeking Alpha
U.S. Markets Finished Mixed Wednesday As United Therapeutics Led, Jabil Lagged - Barron's
LQDA Stock Eyes Worst Day Ever After Judge Upholds Two UTHR Patent Claims - Yahoo Finance
Liquidia slumps after US court rules for United Therapeutics in patent fight - Yahoo Finance
UTHR Stock Jumps As Tyvaso Win And Massive Buyback Fuel Momentum - StocksToTrade
Liquidia shares crater after court rules for United Therapeutics - uk.finance.yahoo.com
Liquidia plunges after court ruling in United Therapeutics patent fight (LQDA:NASDAQ) - Seeking Alpha
United Therapeutics Corp Stock (UTHR) Moved Up by 12.20% on Sep 30: Key Drivers Unveiled - TradingKey
After exercising options, a family trust sold 9,500 United Therapeutics (UTHR) shares under a trading plan. - Stock Titan
ETFs Investing in United Therapeutics Corporation Stocks - TradingView
10 Health Care Stocks Whale Activity In Today’s Session - Benzinga
United Therapeutics (UTHR): Goldman Says Sell As The Base Business Shrinks, But 2027 Holds Real Catalysts - Yahoo Finance
After exercising stock options, the CEO’s family trust sold 9,500 United Therapeutics (UTHR) shares. - Stock Titan
United Therapeutics (UTHR) Falls On Goldman Sell Call, Is It Still 29% Undervalued? - Yahoo Finance
United Therapeutics Corporation (UTHR) stock price, news, quote and history - Yahoo Finance Australia
United Therapeutics chairperson & CEO sells $4.7m in stock By Investing.com - Investing.com South Africa
United Therapeutics chairperson & CEO sells $4.7m in stock - Investing.com
Form 4 United Therapeutics Corporation For: 26 September By Investing.com - Investing.com UK
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
After exercising stock options, the CEO's family trust sold 9,500 United Therapeutics (UTHR) shares. - Stock Titan
United Therapeutics Maps 14 Launches, Fibrosis Growth and Xenokidney Ambitions - Yahoo Finance
UTHR News | UNITED THERAPEUTICS CORP (NASDAQ:UTHR) - ChartMill
Why United Therapeutics (UTHR) Shares Are Falling Today - Yahoo Finance
United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History - Yahoo! Finance Canada
A Look at United Therapeutics Corp (UTHR) After 3.5% Decline -- GF Value $427.97 vs Price $472.21 - GuruFocus
United Therapeutics CEO Rothblatt sells $4.67m in stock after option exercise - Investing.com Nigeria
Form 4 United Therapeutics Corporation For: 24 September - Investing.com India
Form 4 United Therapeutics Corporation For: 24 September By Investing.com - Investing.com Canada
United Therapeutics Insider Sold Shares Worth $4,669,918, According to a Recent SEC Filing - marketscreener.com
After exercising 9,500 options, family trusts sold United Therapeutics (UTHR) shares under a pre-arranged plan. - Stock Titan
United Therapeutics Falls as Goldman Sachs Sets $321 Price Target - citybiz
United Therapeutics, Sagimet drop as Goldman issues Sell (UTHR) - Seeking Alpha
United Therapeutics (NASDAQ:UTHR): A Growth-at-a-Reasonable-Price Candidate - ChartMill
Goldman Sachs initiates United Therapeutics stock with sell rating By Investing.com - Investing.com Australia
Goldman Sachs initiates United Therapeutics stock with sell rating - Investing.com
Under a pre-arranged plan, United Therapeutics (UTHR) CEO’s family trusts exercise 9,500 options and sell the shares. - Stock Titan
United Therapeutics: Strong Catalyst Flow Bodes Well For Near-Term Growth (NASDAQ:UTHR) - Seeking Alpha
United Therapeutics Corporation at Bernstein Healthcare Forum Transcript - gurufocus.com
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):